Dousheng Bai

机构：Northern Jiangsu People's Hospital · ORCID：0000-0001-8032-7959

发表论文 130 篇 · 总被引 2037 次 · h-index 25

代表论文

• Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 20)
• Determination of imatinib as anticancer drug in serum and urine samples by electrochemical technique using a chitosan/graphene oxide modified electrode (2024 · Alexandria Engineering Journal · 被引 18)
• Effects of Indocyanine Green (ICG) Imaging-Assisted Cholecystectomy on Intraoperative and Postoperative Complications: A meta-Analysis (2024 · Surgical Innovation · 被引 13)
• Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study (2023 · Frontiers in Microbiology · 被引 13)
• Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma (2024 · Biomaterials Science · 被引 12)
• TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway (2025 · Translational Oncology · 被引 11)